...
首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway.
【24h】

Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway.

机译:尿激酶诱导的人血管平滑肌细胞迁移需要将小GTPases RhoA和Rac1偶联至Tyk2 / PI3-K信号通路。

获取原文
获取原文并翻译 | 示例
           

摘要

Urokinase-type plasminogen activator (uPA) facilitates cell migration by localizing proteolisys on the cell surface and by inducing intracellular signalling pathways. In human vascular smooth muscle cell (VSMC) uPA stimulates migration via the uPA receptor (uPAR) signalling complex containing the Janus kinase Tyk2 and phosphatidylinositol 3-kinase (PI3-K). We report that active GTP-bound forms of small GTPases RhoA and Rac1, but not Cdc42, are directly associated with Tyk2 and PI3-K in an uPA/uPAR-dependent fashion. Endogenous RhoA, but not Rac1 or Cdc42, was significantly activated in response to uPA. RhoA activation was abolished by cell treatment with two unrelated, structurally distinct, specific inhibitors of PI3-K, wortmannin, and LY294002. Downstream of RhoA, phosphorylation of myosin light chain (MLC) was dramatically upregulated by uPA in a Rho kinase- and PI3-K-dependent manner. Thus, selective Rho kinase inhibitor Y27632 and PI3-K inhibitors wortmannin and LY294002 prevented the uPA-induced stimulation of MLC phosphorylation. Rho kinase inhibition also decreased uPA-stimulated VSMC migration as observed in a Boyden chamber. VSMC immunocytochemical staining demonstrated redistribution of RhoA and Rac1 active forms to the newly formed leading edge of migrating cell. VSMC microinjection with antibodies to either Rho or Rac1 decreased uPA-stimulated cell migration, indicating the involvement of both GTPases in the migration process. Our results provide evidence that the small GTPases RhoA and Rac1, together with Rho kinase, are necessary to mediate the uPA/uPAR-directed migration via the Tyk2/PI3-K signalling complex in human VSMC.
机译:尿激酶型纤溶酶原激活剂(uPA)通过将proteolisys定位在细胞表面并诱导细胞内信号通路来促进细胞迁移。在人血管平滑肌细胞(VSMC)中,uPA通过包含Janus激酶Tyk2和磷脂酰肌醇3-激酶(PI3-K)的uPA受体(uPAR)信号复合物刺激迁移。我们报告说,活跃的GTP绑定形式的小GTPases RhoA和Rac1,而不是Cdc42,以uPA / uPAR依赖的方式与Tyk2和PI3-K直接相关。响应uPA,内源性RhoA而非Rac1或Cdc42被显着激活。通过用两种不相关,结构不同的PI3-K特异性抑制剂,渥曼青霉素和LY294002进行细胞处理,可以消除RhoA激活。在RhoA下游,uPA以Rho激酶和PI3-K依赖性方式显着上调了肌球蛋白轻链(MLC)的磷酸化。因此,选择性Rho激酶抑制剂Y27632和PI3-K抑制剂渥曼青霉素和LY294002阻止了uPA诱导的MLC磷酸化刺激。如在博伊登室观察到的,Rho激酶抑制作用还降低了uPA刺激的VSMC迁移。 VSMC免疫细胞化学染色显示RhoA和Rac1活性形式向迁移细胞新形成的前沿重新分布。 VSMC微注射Rho或Rac1抗体可降低uPA刺激的细胞迁移,表明这两个GTPases均参与迁移过程。我们的结果提供了证据,表明小的GTPases RhoA和Rac1以及Rho激酶是介导人VSMC中通过Tyk2 / PI3-K信号复合物介导uPA / uPAR定向迁移的必需物质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号